AU5100696A - Specific hiv-1 group o antigens - Google Patents

Specific hiv-1 group o antigens

Info

Publication number
AU5100696A
AU5100696A AU51006/96A AU5100696A AU5100696A AU 5100696 A AU5100696 A AU 5100696A AU 51006/96 A AU51006/96 A AU 51006/96A AU 5100696 A AU5100696 A AU 5100696A AU 5100696 A AU5100696 A AU 5100696A
Authority
AU
Australia
Prior art keywords
antigens
group
specific hiv
hiv
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51006/96A
Inventor
Marcus Josephus Marie Koolen
Wilhelmus Joseph Gerardus Schielen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU5100696A publication Critical patent/AU5100696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU51006/96A 1995-03-02 1996-02-29 Specific hiv-1 group o antigens Abandoned AU5100696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95200516 1995-03-02
EP95200516 1995-03-02
PCT/EP1996/000848 WO1996027012A1 (en) 1995-03-02 1996-02-29 Specific hiv-1 group o antigens

Publications (1)

Publication Number Publication Date
AU5100696A true AU5100696A (en) 1996-09-18

Family

ID=8220061

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51006/96A Abandoned AU5100696A (en) 1995-03-02 1996-02-29 Specific hiv-1 group o antigens

Country Status (2)

Country Link
AU (1) AU5100696A (en)
WO (1) WO1996027012A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775287B1 (en) * 1998-02-24 2000-11-24 Pasteur Sanofi Diagnostics CONSENSUS SYNTHETIC PEPTIDES FOR USE IN BIOLOGICAL TRIALS FOR THE DETECTION OF GROUP O HIV 1 VIRUS INFECTIONS
FR2761993B1 (en) * 1997-04-09 1999-05-21 Pasteur Sanofi Diagnostics SYNTHETIC PEPTIDES FOR USE IN BIOLOGICAL TRIALS FOR THE DETECTION OF HIV VIRUS INFECTIONS 1 GROUP 0
ES2275305T3 (en) * 1997-04-09 2007-06-01 Bio-Rad Pasteur SYNTHETIC PEPTIDES USED IN BIOLOGICAL TESTS FOR THE DETECTION OF INFECTIONS DUE TO THE HIV-1 VIRUSES OF GROUP O.
WO1999004011A2 (en) * 1997-07-18 1999-01-28 Innogenetics N.V. Hiv-1 group o antigens and uses thereof
DE102006012885A1 (en) * 2006-03-18 2007-09-20 Institut Virion/Serion Gmbh Diagnostic test system for the simultaneous, quantitative detection of HIV1 and HIV2 antibodies and / or HIV antigens in human sample material

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3443809B2 (en) * 1992-03-06 2003-09-08 エヌ・ブイ・インノジェネティクス・ソシエテ・アノニム A method for determining a peptide corresponding to an immunologically important epitope, its use in a method for determining a biotinylated peptide or an antibody corresponding to an immunologically important epitope, a method for preparing the same, and a composition containing the same
JP3277045B2 (en) * 1992-10-06 2002-04-22 デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング HIV-group retroviruses and uses thereof

Also Published As

Publication number Publication date
WO1996027012A1 (en) 1996-09-06

Similar Documents

Publication Publication Date Title
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU4877896A (en) Preparation
AU6000496A (en) Phenylpyridazinones
AU5896396A (en) Pyridine-microbicides
AU1030997A (en) Taphane
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AUPN178995A0 (en) Antigen composition
AU4580096A (en) Forms stacker
AU5147496A (en) Fucopeptides
AUPN088395A0 (en) Structural member
AU6820796A (en) Antigenic preparations
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU6235496A (en) Azothiophenes
AU5500196A (en) Anti-transpirants
AU4382896A (en) Acetylimidazobenzodiazepines
AU5108596A (en) Morphine-3-esters
AU5100696A (en) Specific hiv-1 group o antigens
AU5917896A (en) Poly-beta-1-4-N-acetylglucosamine
AU6215196A (en) Piperidinylmethyloxazolidinones
AU5013796A (en) Wireclamp
AU5107096A (en) Haemodialyser
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU6658396A (en) Polyhydroxyalkylamidobetaine
AU1205497A (en) Vaccine component